CareTrust REIT (CTRE)
(Delayed Data from NYSE)
$24.31 USD
+0.36 (1.50%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $24.31 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for CareTrust REIT, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 218 | 196 | 192 | 178 | 163 |
Cost Of Goods | 6 | 4 | 4 | 3 | 3 |
Gross Profit | 212 | 192 | 189 | 176 | 160 |
Selling & Adminstrative & Depr. & Amort Expenses | 76 | 76 | 93 | 71 | 70 |
Income After Depreciation & Amortization | 135 | 116 | 96 | 105 | 90 |
Non-Operating Income | -41 | -94 | 0 | 0 | -16 |
Interest Expense | 41 | 30 | 24 | 24 | 28 |
Pretax Income | 54 | -8 | 72 | 81 | 46 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 54 | -8 | 72 | 81 | 46 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 54 | -8 | 72 | 81 | 46 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 194 | 175 | 164 | 163 | 148 |
Depreciation & Amortization (Cash Flow) | 58 | 58 | 68 | 59 | 58 |
Income After Depreciation & Amortization | 135 | 116 | 96 | 105 | 90 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 106.15 | 96.70 | 96.09 | 95.21 | 93.10 |
Diluted EPS Before Non-Recurring Items | 0.50 | -0.08 | 0.74 | 0.85 | 0.49 |
Diluted Net EPS (GAAP) | 0.50 | -0.08 | 0.74 | 0.85 | 0.49 |
Fiscal Year end for CareTrust REIT, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 59.73 | 55.88 | 51.55 | 50.61 |
Cost Of Goods | NA | 1.73 | 2.17 | 1.39 | 0.88 |
Gross Profit | NA | 58.00 | 53.71 | 50.16 | 49.73 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 21.24 | 19.79 | 18.10 | 17.30 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 36.76 | 33.92 | 32.06 | 32.43 |
Non-Operating Income | NA | -2.72 | -13.48 | -21.52 | -3.37 |
Interest Expense | NA | 8.27 | 11.75 | 11.04 | 9.83 |
Pretax Income | NA | 26.29 | 8.69 | -0.48 | 19.23 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | -0.01 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 26.29 | 8.69 | -0.48 | 19.23 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 26.30 | 8.70 | -0.48 | 19.23 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 121.68 | 104.31 | 99.12 | 99.09 |
Diluted EPS Before Non-Recurring Items | NA | 0.22 | 0.08 | 0.00 | 0.19 |
Diluted Net EPS (GAAP) | NA | 0.24 | 0.08 | -0.01 | 0.19 |